
# Title 21 - Food and Drugs
## Chapter I - Food and Drug Administration, Department of Health and Human Services
### Subchapter F - Biologics
#### PART 601 - LICENSING
##### Subpart G - Postmarketing Studies
###### ยง 601.70 Annual progress reports of postmarketing studies.
####### Public disclosure of information.

(e)Except for the information described in this paragraph, FDA may publicly disclose any information concerning a postmarketing study, within the meaning of this section, if the agency determines that the information is necessary to identify an applicant or to establish the status of the study including the reasons, if any, for failure to conduct, complete, and report the study. Under this section, FDA will not publicly disclose trade secrets, as defined in ยง 20.61 of this chapter, or information, described in ยง 20.63 of this chapter, the disclosure of which would constitute an unwarranted invasion of personal privacy.
